Effects of oleic acid on cell proliferation through an integrin-linked kinase signaling pathway in 786-O renal cell carcinoma cells

Oncology Letters

Volumn 5, Issue 4, 2013, Pages 1395-1399

  Liu, Zhenhua ^a   Xiao, Yunbei ^a   Yuan, Yeqing ^a   Zhang, Xiaowei ^a   Qin, Caipeng ^a   Xie, Jing ^a   Hao, Yichang ^a   Xu, Tao ^a   Wang, Xiaofeng ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Cell proliferation; Integrin linked kinase; Oleic acid; Renal cell carcinoma

Indexed keywords

FATTY ACID; G PROTEIN COUPLED RECEPTOR 40; INTEGRIN LINKED KINASE; LIPOCORTIN 5; OLEIC ACID; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY ACID BLOOD LEVEL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; KIDNEY CARCINOMA; METABOLIC DISORDER; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 84874436348     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1160     Document Type: Article

References (27)

1. Sourbier C and Massfelder T: Parathyroid hormone-related protein in human renal cell carcinoma. Cancer Lett 240: 170-182, 2006.
2. Schrader AJ, Varga Z, Hegele A, Pfoertner S, Olbert P and Hofmann R: Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches. J Cancer Res Clin Oncol 132: 137-149, 2006.
3. Tolle A, Jung M, Lein M, et al: Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer? BMC Cancer 9: 248, 2009.
4. Escudier B: Advanced renal cell carcinoma: current and emerging management strategies. Drugs 67: 1257-1264, 2007.
5. Habib SL, Prihoda TJ, Luna M and Werner SA: Diabetes and risk of renal cell carcinoma. J Cancer 3: 42-48, 2012.
6. Drabkin HA and Gemmill RM: Obesity, cholesterol and clear-cell renal cell carcinoma (RCC). Adv Cancer Res 107: 39-56, 2010.
7. Navarro-Tito N, Soto-Guzman A, Castro-Sanchez L, Martinez-Orozco R and Salazar EP: Oleic acid promotes migration on MDA-MB-231 breast cancer cells through an arachidonic acid-dependent pathway. Int J Biochem Cell Biol 42: 306-317, 2010.
8. Suburu J and Chen YQ: Lipids and prostate cancer. Prostaglandins Other Lipid Mediat 98: 1-10, 2012.
9. Yun MR, Lee JY, Park HS, et al: Oleic acid enhances vascular smooth muscle cell proliferation via phosphatidylinositol 3-kinase/Akt signaling pathway. Pharmacol Res 54: 97-102, 2006.
10. Vinciguerra M, Carrozzino F, Peyrou M, et al: Unsaturated fatty acids promote hepatoma proliferation and progression through downregulation of the tumor suppressor PTEN. J Hepatol 50: 1132-1141, 2009.
11. Hannigan G, Troussard AA and Dedhar S: Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer 5: 51-63, 2005.
12. McDonald PC, Oloumi A, Mills J, et al: Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res 68: 1618-1624, 2008.
13. Soto-Guzman A, Navarro-Tito N, Castro-Sanchez L, Martinez-Orozco R and Salazar EP: Oleic acid promotes MMP-9 secretion and invasion in breast cancer cells. Clin Exp Metastasis 27: 505-515, 2010.
14. Stemmer K, Perez-Tilve D, Ananthakrishnan G, et al: High-fat-diet-induced obesity causes an inflammatory and tumor-promoting microenvironment in the rat kidney. Dis Model Mech 5: 627-635, 2012.
15. Bartsch H, Nair J and Owen RW: Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Carcinogenesis 20: 2209-2218, 1999.
16. Willett WC: Specific fatty acids and risks of breast and prostate cancer: dietary intake. Am J Clin Nutr 66: 1557S-1563S, 1997.
17. Han S, Sun X, Ritzenthaler JD and Roman J: Fish oil inhibits human lung carcinoma cell growth by suppressing integrin-linked kinase. Mol Cancer Res 7: 108-117, 2009.
18. Hammamieh R, Chakraborty N, Miller SA, et al: Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res Treat 101: 7-16, 2007.
19. Soto-Guzman A, Robledo T, Lopez-Perez M and Salazar EP: Oleic acid induces ERK1/2 activation and AP-1 DNA binding activity through a mechanism involving Src kinase and EGFR transactivation in breast cancer cells. Mol Cell Endocrinol 294: 81-91, 2008.
20. Gorjao R, Hirabara SM, de Lima TM, Cury-Boaventura MF and Curi R: Regulation of interleukin-2 signaling by fatty acids in human lymphocytes. J Lipid Res 48: 2009-2019, 2007.
21. Persad S and Dedhar S: The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastasis Rev 22: 375-384, 2003.
22. Del GS, Bugliani M, D'Aleo V, et al: G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: the role of type 2 diabetes and fatty acids. Nutr Metab Cardiovasc Dis 20: 22-25, 2010.
23. Briscoe CP, Tadayyon M, Andrews JL, et al: The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem 278: 11303-11311, 2003.
24. Yonezawa T, Katoh K and Obara Y: Existence of GPR40 functioning in a human breast cancer cell line, MCF-7. Biochem Biophys Res Commun 314: 805-809, 2004.
25. Hardy S, St-Onge GG, Joly E, Langelier Y and Prentki M: Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem 280: 13285-13291, 2005.
26. Hanada M, Feng J and Hemmings BA: Structure, regulation and function of PKB/AKT - a major therapeutic target. Biochim Biophys Acta 1697: 3-16, 2004.
27. Dong LQ and Liu F: PDK2: the missing piece in the receptor tyrosine kinase signaling pathway puzzle. Am J Physiol Endocrinol Metab 289: E187-E196, 2005.